CAFs can be transformed from myofibroblasts in tumor tissues and display high activity of PDGF, JAK/STAT signaling, TGF-β, and hypoxia-induced pathways, which contribute to extracellular matrix, remodeling, angiogenesis, and tumor progression. The gene discussed is TGFB1; the disease is neoplasm.